Akston Biosciences >>
akstonbio.com
Actively hiring
Veterinary Medicine
Biotechnology
Health Care
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Grants
$3.9M
2 grants · CORDIS
Backers
1
Boston Harbor Angels
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Funding rounds
Backed byfrom the funds' portfolios and accelerator catalogs
Boston Harbor Angels Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
We design and develop next-generation electroretinography (ERG) products for human and veterinary use.
About Pawlytics Better animal rescue software built by people passionate about pets, determined to engineer a paw-sitive impact.
Filu is a German operator of veterinary practices offering internal medicine, surgery, dentistry, emergency and preventive care for pets…
vetevo is a Berlin veterinary technology company founded in 2018 that offers diagnostics and health plans for pets. Its at-home test kits…
Koala Health is a company dedicated to simplifying pet medication by providing a seamless service that verifies prescriptions, sorts and…
Vilintra partners with pharma and biotech, delivering end-to-end trial management solutions with automation, compliance, and bioequivalence…
News
Akston's NGF-Targeting Ambifect Candidates Demonstrate Clinically Meaningful Osteoarthritis Pain and Function Improvements Comparable to Bedinvetmab in Head-to-Head Canine Study
Data presented at the 2026 American College of Veterinary Internal Medicine (ACVIM) Forum showed that AKS-548d and AKS-734 induced sustained anti-NGF antibody responses, functional neutralization of NGF binding to TrkA, clinically meaningful reductions in
Read more
Report
Akston's AKS-699 Demonstrates Pruritus Control Sustained Through One Year, Comparable to lokivetmab with Fewer Treatments, in Head-to-Head Canine IL-31 Challenge Study
Data presented at the North American Veterinary Dermatology Forum (NAVDF) demonstrated greater than 80% reduction in pruritus sustained through one year following an initial three-dose induction regimen and a single six-month booster, with antipruritic ac
Read more
Report
Akston Chooses Louisiana for Major Life Sciences Manufacturing Expansion
BEVERLY, Mass. (Febuary, 2026) Louisiana Economic Development SHREVEPORT, La. - Akston, a biotechnology company focused on animal health, has opened a new manufacturing facility as part of a $7 million investment in Caddo Parish to expand its U.S. manufac
Read more
Report
Akston Initiates Clinical Trial of Once-Weekly GLP-1 Weight-Management Therapy for Cats
BEVERLY, Mass. (November 25, 2025) PRNewswire BEVERLY, Mass., Nov. 25, 2025 /PRNewswire/ - Akston, the Biotech Built for Pets, announced today the start of a clinical study at Cornell University College of Veterinary Medicine to evaluate its once-weekly G
Read more
Report
Akston Expands Leadership Team with Appointment of Two Veterinarians to Advance First-in-Class Biologics for Pets
BEVERLY, Mass. (August 19, 2025) DVMs Antonella Borgatti and Kristina Kalevas Camp join to advance Akston's pipeline of first-in-class biologics for cancer, chronic pain, dermatitis, and obesity in pets BEVERLY, Mass., Aug. 19, 2025 /PRNewswire/ - Akston,
Read more
Report
Akston Named Best Start-Up at the 2024 S&P Global Animal Health Awards
Akston CEO Todd Zion (right) accepts the 2024 Best Start-Up Award from Joseph Harvey, Editor at S&P Global Animal Health LONDON and BEVERLY, Mass. (February 16, 2025) - Akston, the biotech built for pets, has been awarded the Best Start-Up of 2024 by S&P
Read more
Report
Purdue University and Akston Biosciences Bring "First Dose of Hope" in New Cancer Immunotherapy Trial for Dogs with Urinary Bladder Cancer
Study enrolls dogs with urothelial carcinoma to assess anti-cPD-L1 monoclonal antibody (mAb) safety and efficacy, with potential applications for human treatments. WEST LAFAYETTE, Ind., and BEVERLY, Mass. (November 19, 2024) - Purdue University and its Co
Read more
Report
Energesis and Akston Biosciences Sign Partnership Agreement for Companion Animal Obesity Drug Development
BEVERLY, Mass. & CAMBRIDGE, Mass.-(BUSINESS WIRE)-Akston Biosciences Corporation, dedicated to accelerating the biologics revolution in animal health, and Energesis Pharmaceuticals, Inc., a human biopharmaceutical company focused on the discovery and deve
Read more
Report
Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development
BEVERLY, Mass. and WEST LAFAYETTE, Ind. - August 13, 2024 - Akston Biosciences Corporation, dedicated to accelerating the biologics revolution in Animal Health, and Purdue University, today announced a strategic partnership to co-develop an anti-cPD-L1 mo
Read more
Report
Dechra Purchases Veterinary Insulin Programs from Akston Biosciences
NORTHWICH, England and BEVERLY, Mass. - July 30, 2024 - Dechra Limited, a global specialist veterinary pharmaceuticals and related products business, and Akston Biosciences Corporation, dedicated to accelerating the biologics revolution in Animal Health,
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Beverly
United States
HQ
10-50 est. staff